Request Demo
Last update 28 Feb 2026
HH-006
Last update 28 Feb 2026
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms HH 006, HH006 |
Target |
Action inhibitors |
Mechanism HBV pre-S1 inhibitors(HBV pre-S1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with HH-006CTR20244743
评估HH-006注射液在未经治疗慢性乙型肝炎病毒感染者中多次给药的安全性、耐受性、药代动力学特征和初步抗病毒活性的随机、双盲、安慰剂对照的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary antiviral activity of HH-006 injection after multiple doses in untreated chronic hepatitis B virus infected patients
NCT05275465
A Randomized, Placebo-controlled, Single-Ascending Dose Phase Ia Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers
CTR20260608
评估HH-006在慢性乙型肝炎病毒感染者中多次给药的有效性和安全性的II期临床研究
[Translation] A Phase II clinical study evaluating the efficacy and safety of HH-006 with multiple doses in patients with chronic hepatitis B virus infection.
100 Clinical Results associated with HH-006
Login to view more data
100 Translational Medicine associated with HH-006
Login to view more data
100 Patents (Medical) associated with HH-006
Login to view more data
100 Deals associated with HH-006
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B, Chronic | Phase 2 | China | 25 Feb 2026 | |
| Hepatitis B | Phase 1 | Australia | 03 May 2022 | |
| Hepatitis D | Phase 1 | China | 30 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free